Soluble Interleukin-6 Receptor is a Prognostic Marker for Relapse-Free Survival in Estrogen Receptor-Positive Breast Cancer

By Won Hye Sung   Kim Young Ae   Lee Jun Sang   Jeon Eun Kyoung   An Ho Jung   Sun Der Sheng   Ko Yoon Ho   Kim Jeong Soo  

Cancer Investigation, Vol. 31, Iss. 8, 2013-10 ,pp. : 516-521

Informa Healthcare

Access to resources Recommend Favorite

Estrogen receptor and breast cancer

By Sommer S.   Fuqua S.A.W.  

Seminars in Cancer Biology, Vol. 11, Iss. 5, 2001-10 ,pp. : 339-352

Academic Press

Access to resources Recommend Favorite

Estrogen therapy and breast cancer

By  

Future Oncology, Vol. 2, Iss. 3, 2006-06 ,pp. : 329-331

Future Medicine

Access to resources Recommend Favorite

Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer

By Yoshimoto Nobuyasu   Toyama Tatsuya   Takahashi Satoru   Sugiura Hiroshi   Endo Yumi   Iwasa Mai   Fujii Yoshitaka   Yamashita Hiroko  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 331-339

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen and Progesterone Receptors in the Endometrium of Postmenopausal Breast Cancer Patients Treated with Tamoxifen and Progestogens

By Cohen I.   Altaras M.M.   Beyth Y.   Shapira J.   Figer A.   Tepper R.   Cordoba M.   Yigal D.   Bernheim J.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 83-88

Elsevier

Access to resources Recommend Favorite